The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.
Heath
Elisabeth I
EI
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA. heathel@jhmi.edu
DeWeese
Theodore L
TL
Partin
Alan W
AW
De Marzo
Angelo M
AM
Groopman
John D
JD
Nelson
William G
WG
Piantadosi
Steven A
SA
Lieberman
Ron
R
Carducci
Michael A
MA
D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D011720:Pyrazoles; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib